Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: MAPP BIOPHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2020-09-30 to 2026-06-30
Current total value of award: $16413163
Description: THE PURPOSE OF THIS IS TO UPDATE ARTICLES B.2, B.3, F.2(A) AND ARTICLE G.1, G.5, EXTEND POP FOR CLIN 0001, CLIN 0004, CLIN 0005, AND PROVIDE SUPPLEMENTAL FUNDING UNDER CLIN0001.